opioids
FDA accepts new drug application for Orexo’s opioid overdose medication
November 28, 2023Research and Development FDA, Opioid overdose, Pharmacy, opioids, orexo
Orexo has announced that its New Drug Application (NDA) for OX124 has been accepted for review by the US Food …
FDA approves a second OTC naloxone nasal spray
July 31, 2023Medical Communications FDA, Nasal Spray, OTC, OTC Products, naloxone, opioids
The US Food and Drug Administration (FDA) has announced that it has approved RiVive, 3mg naloxone hydrochloride nasal spray for …
FDA approves prescription nasal spray for opioid overdose treatment
May 23, 2023Medical Communications FDA, Nasal Spray, Opvee, Poisoning and drug dependency, opioids, overdose
The US Food and Drug Administration (FDA) has announced that it has approved Opvee, the first nalmefene hydrochloride nasal spray …
Johnson & Johnson to contribute a further $1 billion to US opioid settlement
October 14, 2020Research and Development, Sales and Marketing J&J, JJ, opioid crisis, opioids, pharma
Johnson & Johnson will pay another $1 billion to settle lawsuits alleging it fuelled the opioid crisis in the US. …
Canada to roll out automated drug dispensers to help fight opioid crisis
August 27, 2020Research and Development opioid, opioid crisis, opioids
Canada is set to roll out automated drug dispensers that can provide clean, doctor-prescribed medicine to opioid addicts by scanning …
US states seek $26.4 billion from major pharmaceutical manufacturers and distributors to settle opioid litigation
August 19, 2020Research and Development opioid crisis, opioid epidemic, opioids
Multiple Attorney Generals from across the US are seeking billions of dollars in damages to settle opioid cases against major …
FDA approves opioid Olinvyk for patients with acute pain
August 10, 2020Sales and Marketing opioid crisis, opioids
The FDA has approved Olinvyk for the management of moderate to severe pain in adult patients when their pain is …
FDA launches new pilot program to crack down on unapproved opioids sold online
June 9, 2020Manufacturing and Production FDA, opiod crisis, opioids
The FDA is collaborating with the National Telecommunications and Information Administration (NTIA) to launch a pilot program to reduce the …
FDA approval for Baudax Bio’s non-opioid painkiller Anjeso
February 24, 2020Sales and Marketing Anjeso, FDA, opioids, pharma
Baudax Bio has revealed the FDA approval of its non-opioid painkiller Anjeso (meloxicam injection) as a therapy for the management …
Top Ten most popular articles on Pharmafile.com this week
February 21, 2020Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Drug market, Europe, coronavirus, opioid crisis, opioids
The coronavirus is again in the news, with the Indian government considering banning exports of medicine as the epidemic threatens …
Experts call on NICE to recommended a ban on OTC codeine sales
February 17, 2020Research and Development, Sales and Marketing Codein, NICE, opioid crisis, opioids, prescription drugs
Experts have called for a ban on the sale of over the counter codeine as NICE is set to publish …
FDA panel votes against Nektar opioid painkiller
January 15, 2020Research and Development Bernie Opioids, Big Pharma, Trump opioids, opioid, opioid crisis, opioids, pharma
FDA unanimously voted against Nektar Therapeutics opioid pankiller (NKTR-181) for chronic lower back pain, prompting the company to withdraw its …
Rochester Drug Cooperative ceases opioid sales following criminal charges
January 15, 2020Research and Development Bernie Sanders, Trump opioids, opioid, opioid crisis, opioids
The Rochester Drug Cooperative (RDC) has announced it will no longer distribute opioid medications after two of its executives were …
Pharmacies argue that prescribers bear ultimate responsibility for the opioid crisis
January 8, 2020Research and Development Bernie Sanders, OxyContin, opioid crisis, opioids
Pharmacy chains have argued in federal court that doctors and healthcare practitioners who write prescriptions bear ultimate responsibility for the …
Johnson & Johnson sued by Washington State for role in the opioid crisis
January 3, 2020Medical Communications Bernie Sanders, Johnson & Johnson, OxyContin, fentanyl, opioid crisis, opioids
The state of Washington sued pharmaceutical company Johnson & Johnson for deceptive marketing that said their opioids were effective for …
